Flemington, NJ, United States of America

Barbara S Rauckman




Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 85(Granted Patents)


Company Filing History:


Years Active: 1994-2012

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):

Title: Barbara S Rauckman: A Pioneer in Pharmaceutical Innovation

Introduction

Barbara S Rauckman, a distinguished inventor residing in Flemington, NJ, has made significant contributions to the field of pharmaceuticals with 20 patents to her name. Her innovative work primarily focuses on compounds that address critical health issues, particularly in the area of respiratory and neurological disorders.

Latest Patents

Among her notable inventions is the patent for Pyrimidine hydrazide compounds as PGDS inhibitors. This invention is dedicated to a specific compound of formula (I), designed to treat allergic and inflammatory disorders such as allergic rhinitis, asthma, and chronic obstructive pulmonary disease (COPD). Another groundbreaking patent involves thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives. These compounds serve as D antagonists, beneficial for treating a variety of medical conditions, including Attention Deficit Hyperactivity Disorder, Obsessive-Compulsive Disorder, Psychoses, Substance Abuse, and Parkinson's Disease. Furthermore, this patent details pharmaceutical compositions, intermediates, and methods for synthesizing these innovative compounds.

Career Highlights

Barbara's career highlights include her pivotal roles at Hoechst Roussel Pharmaceuticals and Hoechst Marion Roussel, where she honed her expertise in pharmaceutical development and innovation. Her relentless pursuit of advancements in medicine showcases her commitment to improving patient care through innovative therapies.

Collaborations

Throughout her career, Barbara has collaborated with other esteemed professionals in her field, including Gregory H Merriman and Brian S Freed. Their combined efforts have contributed to the successful development and patenting of several influential pharmaceutical compounds.

Conclusion

Barbara S Rauckman's impressive portfolio of patents and her collaborative spirit underline her status as a key figure in pharmaceutical innovation. Her dedication to addressing complex medical challenges continues to have a profound impact on the industry and patients worldwide. With her contributions, Barbara paves the way for future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…